Explore the 8,758 U.S. Patent Applications published on the 13th week of 2024, including 397 applications that subsequently received a Patent Grant.
VLP ENTEROVIRAL VACCINES
Messenger RNA vaccines have been developed to protect against enteroviruses by encoding specific proteins that trigger an immune response. These vaccines contain RNA molecules that encode proteins responsible for building the outer shell of the virus and a protease enzyme. Additionally, the vaccines may include RNA molecules that can alter the expression or function of other RNA molecules within the body.
Published: 2024-03-28 Assignee: Microsoft Technology Licensing, LLC.UNIVERSAL HIGHLIGHTER FOR CONTEXTUAL NOTETAKING
This invention allows users to highlight information on a screen and automatically gather related context data for taking notes. It can capture content from windows and applications, determine the context, and generate notes based on the highlighted information. By simplifying the notetaking process and providing enriched data based on context, this technology helps users create and access notes more efficiently.
Published: 2024-03-28 Assignee: APPLE INC..Collaborative Video Recording
A system has been created for collaborative video recording, where multiple recording devices can work together. The system uses a reference clock to keep track of time and provides a synchronization code to all devices. This allows the devices to record videos simultaneously and create a shared timeline with synchronized timestamps.
Published: 2024-03-28METHODS AND COMPOSITIONS FOR GENERATING EMBRYOS IN VITRO FROM PLURIPOTENT STEM CELLS
A method has been developed to create synthetic embryos in a lab using pluripotent stem cells. By combining regular stem cells with modified ones containing specific genes, these cells can self-organize into embryo structures. This technology can be used to generate human embryos from pluripotent embryonic stem cells.
Published: 2024-03-28ANTI-PD-1/LAG-3 BISPECIFIC ANTIBODIES AND USES THEREOF
A new type of antibody has been created to fight advanced cancers like melanoma and head and neck squamous cell carcinoma. This antibody targets two specific proteins, PD-1 and LAG-3, to enhance the body's immune response against these types of cancer. The invention aims to improve treatment options for patients with these challenging malignancies.
Published: 2024-03-28AUGMENTED REALITY SPATIAL AUDIO EXPERIENCE
An eyewear device with spatial audio technology creates an immersive augmented reality experience. It captures images of the surroundings, identifies objects, and overlays virtual objects in the real world. The device tracks the user's position and uses audio signals to guide them towards the identified objects in the environment.
Published: 2024-03-28MONOCLONAL ANTIBODIES AGAINST CORONAVIRUSES AND USES THEREOF
Monoclonal antibodies have been created to target the spike proteins found on different types of coronaviruses, including SARS-CoV-2. These antibodies can effectively bind to specific parts of the spike protein and show potential to work against various coronaviruses. The invention includes not only the antibodies themselves but also methods for diagnosing, preventing, and treating coronavirus infections, particularly those caused by SARS-CoV-2.
Published: 2024-03-28 Assignee: APPLE INC..DECOUPLED AND COORDINATED CONTROL OF REFRIGERATION CLIMATE CONTROL SYSTEMS
These techniques help multiple refrigeration systems work together efficiently. They gather climate control data and receive signals about the energy source. Then, they create control signals for each system to operate optimally using the available electricity.
Published: 2024-03-28SARS-COV-2 CONSTRUCTS, VACCINES, AND METHODS
An antibody that fights against a specific immune system protein is combined with a part of the SARS-CoV-2 virus. This combination is used to create a vaccine for treating and preventing SARS-CoV-2 infection. The vaccine does not contain any additional substances to enhance its effectiveness.
Published: 2024-03-28 Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATION.COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY
A new discovery shows that a specific pathway in the eye cells leads to degeneration in age-related macular degeneration and geographic atrophy. This pathway involves certain proteins like caspase-4, caspase-1, and cGAS, which trigger inflammation and damage in the cells. Understanding this process could help develop treatments to target these proteins and potentially prevent vision loss in these eye conditions.